Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses in Phase 3 Trial
| | | | |

Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses in Phase 3 Trial

On Jun. 11, 2025, Novavax announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent…

Europe pledges half a billion euros to lure scientists as Trump battles universities
| | | | | | | | | | | | | |

Europe pledges half a billion euros to lure scientists as Trump battles universities

On May 5, 2025, The European Union (EU) and France announced half a billion euros worth of incentives…

Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published
| | | | | | | | | | | | | | | | | | | | | | | | |

Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published

On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…

National Security Commission on Emerging Biotechnology Urges Swift Action to Protect U.S. National Security
| | | | | | | |

National Security Commission on Emerging Biotechnology Urges Swift Action to Protect U.S. National Security

On Apr. 8, 2025, the National Security Commission on Emerging Biotechnology delivered its major report and action plan…

75% of U.S. scientists who answered Nature poll consider leaving
| | | | | | | | | | | | | | | | | |

75% of U.S. scientists who answered Nature poll consider leaving

On Mar. 27, 2025, a Nature survey of more than 1,200 scientists, three-quarters of the total respondents are…

Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity
| | | | | | | | |

Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity

On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….